Document:

EX-10.2

 Exhibit 10.2 
  

 
 October 5, 2012 

Mr. Michael Morhardt 
 67 Breakneck Hill Road 

Southborough, MA 01772 
 Dear Mike, 

I am pleased to offer you the position of Chief Sales Officer of Forrester Research, Inc. (“Forrester” or the “Company”) in our offices
located at 60 Acorn Park Drive in Cambridge, Massachusetts, reporting to Chief Operating Officer, Charles B. Rutstein. Your start date is November 12, 2012. 

If you accept this offer of employment, your annualized base compensation would be $300.000 ($12,500 semi-monthly), less legally required deductions, paid in
accordance with Forrester’s regular payroll practices (the “Base Salary”). In addition to the Base Salary, effective January 1, 2013, you will be eligible for incentive compensation comprised of: (1) $200,000 of sales
commissions for 100% performance against the Company 2013 operating plan and (2) assuming you are employed by the Company on the last day of the 2013 fiscal year, an annual target bonus of $100,000. The Company will pay you, in accordance with
its normal payroll cycle and subject to required deductions, and without regard to Company performance, a pro rata, portion of your 2013 target annualized commissions and incentive bonus from commencement of employment through December 31,
2012. The actual amount of your 2013 commissions earned and payable will be determined based on your performance and the terms of the Company’s 2013 sales commission plan, and the actual amount of your incentive bonus earned and payable for
2013 will be measured and determined based on 2013 Company performance and other terms under and pursuant to the Company’s Executive Incentive Plan, provided that for the first fiscal quarter of 2013, the Company will pay to you, in accordance
with its normal payroll practices no less than a pro rata share of your annual target Commission opportunity, which equals $50,000. 
 In addition, subject
to your providing to the Company copies of the relevant compensation plan(s) and W-2 statements from your current employer and any other documents that Forrester reasonabley requests with respect to your current compensation, Forrester will award to
you as soon as reasonably practicable after receipt of appropriate documentation establishing (i) the pro rata bonus compensation for which you were eligible for the months worked for your current employer during 2012 (“Bonus
Eligibility”), and (ii) the actual bonus earned and paid to you for 2012 (“Bonus”) by your current employer, pursuant to the Company’s Amended and Restated Equity Incentive Plan (the “Plan”) restricted stock units
with a value equal to the difference between your total Bonus Eligibility (not to exceed $225,000) and the actual Bonus paid to you, and which RSUs will vest 90 days after the date of issuance. For purposes of determining the number of restricted
stock units to be awarded to you, the per share price of Forrester common stock will be determined as of the earlier of March 1, 2013 or the actual date of payment of the Bonus. You must provide to us reasonable documentation establishing your
Bonus Eligibility and Bonus, if any, no later than March 1, 2013 

  
 Page 1 of 3 

 Your next compensation review would be scheduled for January 2014. 

You will be granted an option to purchase 40,000 shares of Forrester’s common stock with an exercise price equal to the closing price of Forrester common
stock on the grant date pursuant to the Plan. During your employment, these options will vest over four years from date of grant. This stock option grant will be awarded on the first business day of the month immediately following your start date.
The stock option grant, and any RSUs awarded to you, will be subject to the terms and conditions of the Plan, as amended from time to time, and any stock option certificate, stock option agreement, restricted stock agreement, and other restrictions
generally applicable to stock options, equity-based awards, and securities of the Company, including without limitation the enclosed Stock Retention Guidelines. 

You will be eligible to participate in Forrester’s employee benefit programs during your employment, consistent with the plan documents and Company
policies. Forrester’s employee benefits are described in the enclosed Employee Benefits at a Glance booklet. Forrester’s employee benefits are subject to change at any time. 

Employment at Forrester is terminable at will. It is understood that your employment is for no definite term and that you may decide to resign from Forrester
at any time without notice and without cause. Subject to the provisions of the next sentence, it is also understood that Forrester, at its option, may terminate your employment at any time with or without notice or Cause, as defined below. Should
Forrester terminate your employment for any reason, other than for Cause, you will be paid, pursuant to Forrester’s regular payroll practices, the Base Salary, as the same may be adjusted from time to time, less required Withholding taxes, for
a period of six months, subject to your signing a separation agreement in a form acceptable to Forrester, which shall include a general release of claims. 

Cause is defined as your malfeasance or negligence in the performance of your duties; fraud or dishonesty by you with respect to the Company; your conviction
of or plea of nolo contendere to any felony or other crime involving moral turpitude; or your breach of any provision of this offer letter or the Employee Confidentiality, Proprietary Rights and Non-Competition Agreement. 

This offer is subject to and contingent upon satisfactory results of a background check, which will include but not necessarily be limited to a check on your
educational and criminal history, as well as your execution of the Company’s Employee Confidentiality, Proprietary Rights and Non-Competition Agreement, a copy of which is enclosed. You will also be required to complete a Form I-9, as required
by the Immigration Reform and Control Act, and provide the appropriate documents listed on that form when you report to work. 
 This offer constitutes the
entire agreement between you and the Company and supersedes all prior understandings, negotiations and agreements, whether written or oral, between you and Forrester as to the subject matter covered by this offer letter, excluding only the Employee
Confidentiality, Proprietary Rights, and Non-competition Agreement and the Plan and any agreements or documents related to the option grant or potential RSU award. 

  
 Page 2 of 3 

 We look forward to you Joining us. Please indicate your agreement by signing below and returning this letter
along with the signed Employee Confidentiality, Proprietary Rights and Non-Competition Agreement in the enclosed envelope. 
 Sincerely, 

 

							
				
	/s/ Elizabeth Lemons	 		 		 	/s/ Michael Morhardt
	 Elizabeth Lemons
 Chief People Officer
	 		 		 	Michael Morhardt
				
		 		 		 	10-7-2012
		 		 		 	Date

  
 Page 3 of 3EX-10.1

 Exhibit 10.1 

ALLSCRIPTS EXECUTION COPY 01/22/14 

SEPARATION AGREEMENT 

This Separation Agreement (this “Agreement”), by and between Deborah D. Snow (“Executive”) and Allscripts
Healthcare Solutions, Inc., a corporation organized and existing under the laws of the State of Delaware (“Company”) is effective as of the 22nd day of January 2014 (the “Effective Date”). 

WHEREAS, Company and Executive desire to set forth the terms of Executive’s termination of employment with the Company, severance
benefits, and other matters related thereto. 
 NOW, THEREFORE, in consideration of the foregoing premises, of the mutual agreements and
covenants contained herein and for other good and valuable consideration the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows: 

1. Termination Date; Cessation of Duties. 

(a) Executive’s employment with Company will terminate effective as of the close of business on the later of:
(1) April 1, 2014; or (2) if Executive begins a leave of absence prior to April 1, 2014, the date that Executive either returns to work from such leave of absence or ceases to be eligible to receive short-term disability
benefits under the Allscripts Healthcare Solutions Short Term Disability Income Benefit Plan (the “Termination Date”). As of the Termination Date, Executive’s service as an officer and employment with Company and any
subsidiaries is terminated and Executive irrevocably resigns from all other positions with any subsidiaries and affiliated companies of Company. 

(b) Executive will remain employed by the Company until the Termination Date, except as modified by this Agreement. Through and including the
Termination Date, Executive shall continue to receive her Base Salary as in effect on the Effective Date and to participate in any benefit plans or programs of Company provided or made available to Executive as of the Effective Date. 

(c) As of the Effective Date, Executive shall have no authority as an officer or agent of Company. Between the Effective Date and the
Termination Date, Executive shall provide consulting, transition and other services at the direction of the General Counsel or Chief Executive Officer of the Company. 

2. Severance Benefits. Subject to Executive’s compliance with the terms of this Agreement, including without limitation Sections 4,
5, 6, 7, 8, and 10, after the Termination Date, Executive shall receive the payments and benefits described in Schedule 1 attached to this Agreement. 

3. No Other Payments. Executive expressly acknowledges and agrees that, other than as specifically provided for in this Agreement and on
Schedule 1, no additional payments or benefits are due from Company on any basis whatsoever and that Executive’s outstanding, unvested equity awards are forfeited as of the Termination Date, other than as described on Schedule 1.

 4. Release. The pay and benefits provided under Section 2 of this Agreement are
subject to Executive’s execution of (without revocation) and delivery to Company by the forty-fifth (45th) day following the Termination Date (but not before the Termination Date) of a release and waiver of all claims (the
“Release”) up to the date of the Release with such Release in the form attached hereto as Exhibit A. 
 5.
Restrictive Covenants. Executive expressly acknowledges and agrees that Sections 3, 4 and 6 (“Restrictive Covenants”) of the Employee Non-Solicitation, Non-Competition and Non-Disclosure Agreement signed by Executive (the
“Restrictive Covenant Agreement”) remain in full force and effect as provided therein; provided that, for purposes of Section 4 of the Restrictive Covenant Agreement, the parties agree that a “Competing Organization” shall
mean only the organizations identified in the list attached hereto as Exhibit B. 
 6. Return of Company Property. Executive
represents and warrants that, within seven days of the Termination Date, Executive shall return to Company all Company property and information in any form (whether, paper, electronic media or otherwise), and not retain copies of any such property
or information (excluding, however, information relating solely to Executive’s own employment, compensation and benefits). 
 7.
Non-Disparagement. Executive agrees not to make any adverse or disparaging comments (oral or written, including but not limited to, via any form of electronic media) about Company, its affiliates, or any of their respective officers,
directors, managers or employees which may tend to impugn or injure their reputation, goodwill and relationships with their past, present and future customers, employees or vendors or with the business community generally. The Company agrees to
instruct those individuals who serve as its executive officers as of the Termination Date not to make any adverse or disparaging comments (oral or written, including but not limited to, via any form of electronic media) about Executive which may
tend to impugn or injure her reputation, good will and business, civic or professional relationships. Nothing in this Section 7 is intended to prohibit, limit or prevent Executive, Company or the Company’s executive officers from
providing truthful testimony in a court of law, to a regulatory or law enforcement agency or pursuant to a properly issued subpoena, and such testimony would not be deemed to be a violation of this Section 7. 

8. Cooperation. Executive agrees to cooperate, within reason, subject to reimbursement by Company of reasonable out of pocket costs and
expenses, with Company and its counsel with respect to any matter (including any litigation, investigation or governmental proceeding) which relates to matters with which Executive was involved during her employment with Company. Such cooperation
shall include appearing from time to time at the offices of Company or Company’s counsel for conferences and interviews and in generally providing the officers of Company and its counsel with the full benefit of Executive’s knowledge with
respect to any such matter. Executive agrees to render such cooperation in a timely fashion and at such times and places as may be mutually agreeable to the parties. Executive’s cooperation shall not require her to give Company more time and
attention than may reasonably be accommodated to her work schedule and other commitments, from time to time. 

  
 2 

 9. Waiver of Any Re-Employment Right. Executive waives all interest in and right to
reinstatement or re-employment with Company and any of its affiliates and agrees that any application for re-employment may be rejected without explanation or liability pursuant to this provision. This waiver shall not apply to any instance where
Executive’s then-current employer becomes acquired by the Company or any of its affiliates, or where the Company desires to re-hire Executive. 

10. Nondisclosure. Executive shall not disclose or cause to be disclosed the terms of this Agreement or the negotiations leading to it
to any person (other than to her spouse, attorneys or tax advisors, who shall also be bound by this nondisclosure provision), except pursuant to a lawful subpoena or as otherwise required by law. 

11. Miscellaneous. 
 (a)
Binding Effect. This Agreement shall be binding upon each of the parties and upon their respective heirs, administrators, representatives, executors, successors and assigns, and shall inure to the benefit of each party and to their respective
heirs, administrators, representatives, executors, successors and assigns. 
 (b) Applicable Law. This Agreement shall be construed in
accordance with the laws of the State of Illinois, without regard to the conflict of law provisions of any jurisdiction. 
 (c) Scope of
Agreement. This Agreement reflects the entire agreement between Executive and Company with respect to the terms and conditions of Executive’s employment relationship with Company and the termination of such employment relationship and,
except as specifically provided herein, supersedes all prior agreements and understandings, written or oral relating to the subject matter hereof. 

(d) Waiver of Breach. The waiver by either party to this Agreement of a breach of any provision of this Agreement shall not operate as
or be deemed a waiver of any subsequent breach by such party. Continuation of benefits hereunder by Company following a breach by Executive of any provision of this Agreement shall not preclude Company from thereafter exercising any right that it
may otherwise independently have to terminate said benefits based upon the same violation. 
 (e) Amendment. This Agreement may not be
modified or amended except by a writing signed by the parties to this Agreement. 
 (f) Counterparts. This Agreement may be signed in
multiple counterparts, each of which shall be deemed an original. Any executed counterpart returned by facsimile or PDF shall be deemed an original executed counterpart. 

(g) No Third Party Beneficiaries. Unless specifically provided herein, the provisions of this Agreement are for the sole benefit of the
parties to this Agreement and are not intended to confer upon any person not a party to this Agreement any rights hereunder. 

  
 3 

 (h) Terms and Construction. Each party has cooperated in the drafting and preparation of
this Agreement. The language in all parts of this Agreement shall be in all cases construed according to its fair meaning and not strictly for or against either party. 

(i) Admissions. Nothing in this Agreement is intended to be, or will be deemed to be, an admission of liability by Executive or Company
to each other, or an admission that they or any of their agents, affiliates, or employees have violated any state, federal or local statute, regulation or ordinance or any principle of common law of any jurisdiction, or that they have engaged in any
wrongdoing towards each other. 
 (j) Withholding. Company may withhold from any amounts payable under this Agreement such federal,
state and local taxes as may be required to be withheld pursuant to applicable laws or regulations. 
 (k) Severability. The holding
of any provision of this Agreement to be illegal, invalid or unenforceable by a court of competent jurisdiction shall not affect any other provisions of this Agreement, which shall remain in full force and effect. 

(l) Calculations. In the event of manifest error in any calculation reflected on Schedule 1, Company and Executive agree that the
calculation shall be corrected and Executive provided the correct payment or benefit. 
 (m) Section 409A of the Code. It is
intended that this Agreement will comply with Section 409A of the of the Internal Revenue Code of 1986, as amended, (“Section 409A”) and any regulations and guidelines issued thereunder to the extent the Agreement is subject thereto,
and the Agreement shall be interpreted on a basis consistent with such intent. No action or failure by Company in good faith to act, pursuant to this Section 11(m), shall subject Company to any claim, liability, or expense, and Company shall
not have any obligation to indemnify or otherwise protect Executive from the obligation to pay any taxes pursuant to Section 409A. 
 Executive is a
“specified employee” of Company and its affiliates (as defined in Treasury Regulation Section 1.409A-1(i)), and Executive is therefore subject to a delay in payment until six months after the date of Executive’s separation from
service from Company (pursuant to Treasury Regulation Section 1.409A-3(i)(2)(ii)) to receive payments provided hereunder to the extent such amounts are subject to, and not exempt from, Section 409A. If the sixty (60)-day period following a
“separation from service” begins in one calendar year and ends in a second calendar year (a “Crossover 60-Day Period”), then any severance payments that would otherwise occur during the portion of the Crossover 60-Day
Period that falls within the first year will be delayed and paid in a lump sum during the portion of the Crossover 60-Day Period that falls within the second year. 

  
 4 

 IN WITNESS WHEREOF, this Agreement has been duly executed by the parties as of the dates
respectively set forth below. 
  

			
		  	 ALLSCRIPTS HEALTHCARE
 SOLUTIONS,
INC.

		
	Dated: 1/22/14	  	/s/ Brian P. Farley
		  	Brian P. Farley
		  	Senior Vice President and General Counsel

  

			
		  	EXECUTIVE:
		
	 Dated: January 22, 2014
	  	 /s/ Deborah D. Snow

		  	Deborah D. Snow
		  	

  
 5 

 SCHEDULE 1 

CASH PAYMENTS 
  

			
	 Amount Payable
	  	 Date[s] Payable

	$465,000	  	Paid in twelve equal monthly installments with the first two installments to be paid on the sixtieth (60th) day following the Termination Date and the remaining ten installments to be paid on the ten following
monthly anniversaries of such date.

 BENEFITS CONTINUATION 
  

			
	 Benefits Description
	  	 Continuation Period

	Continuation of Executive’s enrollment in health and/or dental insurance benefits immediately prior to the Termination Date, with Executive contributing to such benefits as if she were employed by Company.	  	 Until the earlier of:
  

(i)     the end of the 12-month period following the Termination Date; or

 
 (ii)    Executive’s
failure to make a required contribution within 10 days of written notice or the COBRA grace period, whichever comes later; or
  

(iii)  the date on which Executive becomes eligible to receive comparable benefits from a subsequent
employer.

 RESTRICTED STOCK UNIT (“RSU”) AND OPTION VESTING AND FORFEITURE 

Equity Vesting and Forfeiture 
 Solely for
purposes of determining the extent to which any outstanding equity-based compensation awards held by Executive are vested and/or exercisable, Executive will be deemed to have remained employed for an additional 30 days beyond the Termination Date,
such that any equity-based compensation awards that would have become vested and/or exercisable during such 30-day period shall become vested and/or exercisable as of the date of the Termination Date, and, in the case of outstanding stock options or
stock appreciation rights, such awards shall remain exercisable for the period of time set forth in the applicable option award agreement, measured from the Termination Date. 

  
 A-1 

 EXHIBIT A 

GENERAL RELEASE 
 WHEREAS,
this General Release (this “Release”) is given by Deborah D. Snow (“Executive”) on the date indicated below at Executive’s signature, pursuant to the Separation Agreement
between Allscripts Healthcare Solutions, Inc. (the “Company”) and Executive effective as of January 22, 2014 (the “Agreement”); and 

WHEREAS, in consideration for the payments and benefits provided by Company to Executive under the Agreement, which are conditioned upon her
execution of a release and waiver of claims for the benefit of Company, Executive agrees to execute this Release. 
 NOW THEREFORE, in
consideration of the mutual covenants contained under the Agreement and other good and valuable consideration, the sufficiency and receipt of which are hereby acknowledged, and intending to be legally bound, Executive agrees as follows: 

1. In exchange for the benefits described in the Agreement, Executive hereby agrees to WAIVE any and all rights in connection with, and to
fully RELEASE and forever discharge Company and its predecessors, parents, subsidiaries, divisions, related or affiliated companies, benefit plans, plan administrators and other plan fiduciaries, officers, directors, stockholders, members,
employees, heirs, successors, assigns, representatives, agents and counsel (the “Released Parties”) from any and all torts, contracts, claims, suits, actions, causes of action, demands, rights, damages, costs, expenses,
attorneys’ fees, and compensation in any form whatsoever, whether now known or unknown, in law or in equity, which Executive has or ever had (from the beginning of time through and including the date hereof) against any of the Released
Parties, including without limitation on account of or in any way arising out of, relating to or in connection with Executive’s employment by or separation of employment from any of the Released Parties, and any and all claims for damages or
injury to any entity, person, property or reputation arising therefrom, claims for wages, employment benefits, tort claims and claims under Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Civil Rights Act of 1866, the
Employee Retirement Income Security Act of 1974 (except that Executive does not waive her right to receive notices and disclosures, monies and other benefits due in accordance with any employee retirement or welfare benefit plan), the National Labor
Relations Act, the Fair Labor Standards Act, the Rehabilitation Act of 1973, the Family and Medical Leave Act of 1993, the Americans with Disabilities Act of 1990 and any other federal, state or local law, statute, ordinance, guideline, regulation,
order or common-law principle of any state relating to employment, employment contracts, wrongful discharge or any other matter; provided, however, that the foregoing waiver and release shall not apply to Executive’s rights in
respect of any benefit or claim to which Executive is entitled under employee pension or welfare benefit plans and programs of the Released Parties in which Executive is a participant prior to the date below, or to Executive’s rights to enforce
the Agreement. 
 2. Release of Age Discrimination Claims. In further consideration of the promises made by Company in the
Agreement, Executive specifically WAIVES any and all rights in connection with, and fully RELEASES and forever discharges the Released Parties from, any and all torts, contracts, claims, suits, actions, causes of action, demands, rights, damages,
costs, 

  
 A-2 

 expenses, attorneys’ fees, and compensation in any form whatsoever, whether now known or unknown, in law or
in equity, which Executive has or ever had (from the beginning of time through and including the date hereof) against any of the Released Parties, arising under the Age Discrimination in Employment Act of 1967, as amended, 29 U.S.C. Sec. 621, et
seq. (“ADEA”). Executive further agrees that: 
 (a) Executive’s waiver of rights under this Release is
knowing and voluntary and in compliance with the Older Workers Benefit Protection Act of 1990; 
 (b) Executive understands the terms of this
Release; 
 (c) the consideration provided in the Agreement represents consideration over and above that to which Executive otherwise would
be entitled, that the consideration would not have been provided had Executive not signed this Release, and that the consideration is in exchange for the signing of this Release; 

(d) Company is hereby advising Executive in writing to consult with Executive’s attorney prior to executing this Release; 

(e) Company is giving Executive a period of at least forty-five (45) days within which to consider this Release; 

(f) Following the execution of this Release Executive has seven (7) days in which to revoke this Release by written notice. To be
effective, the revocation must be made in writing and delivered to and received by the General Counsel, Allscripts Healthcare Solutions, Inc., 222 Merchandise Mart Plaza, Suite 2024, Chicago, Illinois 60654, no later than 4:00 p.m. on the seventh
day after Executive executes this Release. An attempted revocation not actually received by the General Counsel before the revocation deadline will not be effective; and 

(g) This entire Release shall be void and of no force and effect if Executive chooses to so revoke, and, if Executive chooses not to so revoke,
this Release shall then become fully effective and enforceable. 
 This Section 2 does not waive rights or claims that may arise under
the ADEA after the date Executive signs this Release. In addition, nothing in this Release shall in any way affect Executive’s right to indemnification, coverage and expense advancement to the extent provided by Company’s bylaws or other
applicable Company or insurance policies; provided, however, that Company shall not be liable, and shall not provide a defense and indemnification for any claim wherein Executive has not satisfied the applicable standard of conduct set
forth in such operating agreement or other applicable policies, or wherein Executive has committed any acts of fraud, embezzlement or gross misconduct. 

3. Proceedings; No Admissions. 

(a) Executive hereby represents and warrants that she has no pending claims against any of the Released Parties with any municipal, state,
federal or other governmental or nongovernmental entity. Notwithstanding anything to the contrary, this Release shall not prevent Executive from (A) initiating or causing to be initiated on Executive’s behalf any complaint, 

  
 A-3 

 charge, claim or proceeding against any of the Released Parties before any local, state or federal agency, court
or other body challenging the validity of the waiver of Executive’s claims under the ADEA contained in this Release (but no other portions of the waivers and releases described in Sections 1 or 2); or (B) initiating or participating in an
investigation or proceeding conducted by the Equal Employment Opportunity Commission with respect to the ADEA. 
 (b) Both parties
acknowledge and agree that this Release does not constitute, is not intended to be, and shall not be construed, interpreted or treated in any respect as, and shall not be admissible in any proceeding as, an admission of liability, error, violation,
omission or wrongdoing by either party for any purpose whatsoever. Further, both parties acknowledge and agree that there has been no determination that either party has violated any federal, state or local law, statute, ordinance, guideline,
regulation, order or common-law principle. Executive further acknowledges that no precedent, practice, policy or usage shall be established by this Release or the offer to Executive of compensation and benefits in the Agreement. 

4. Effect of Claim. Executive also understands and agrees that in the event Executive, by himself, or in conjunction with
Executive’s heirs, spouse, family members, executors, or administrators, attempt(s) to institute or institute(s) any charge, claim, suit or action against any of the Released Parties in violation of this Release, Executive shall be obligated,
as an express condition of bringing such action, to tender back to Company the full amount of the compensation and benefits that Executive has received under the Agreement; and Executive further agrees that Executive will pay all of the Released
Parties’ costs, expenses and fees of defending against such action, including, among other things, reasonable attorneys’ fees. The immediately prior sentence does not apply to claims under ADEA or to challenge the release of ADEA claims
under this Release; provided, however, nothing in this Release is intended to reflect any party’s belief that Executive’s waiver of claims under ADEA is invalid or unenforceable under this Release, it being the intent of Executive and
Company that such claims are waived. This Section 4 does not grant Executive an option to return the money and institute an action. Instead this paragraph merely creates an additional term and condition precedent to bringing an action
regardless of the fact that such action is expressly barred by this Release, and is without merit. 
 5. Executive’s Right to
Enforce Agreement. Nothing in this Release shall be construed as a waiver or release by Executive of any claim or right to enforce the terms of the Agreement or to bring a claim for damages arising out of Company’s breach of the
Agreement. 

  
 A-4 

 IN WITNESS WHEREOF, Executive has executed and delivered this Release on the date set forth
below. 
  

									
		 		 		 		 	NOT TO BE SIGNED PRIOR TO THE TERMINATION DATE
					
	 Date:
	 	  
	 		 		 	 
		 		 		 		 	Deborah D. Snow

  
 A-5 

 EXHIBIT B 

For purposes of the Restrictive Covenants set forth in Section 5 of the Restrictive Covenant Agreement, any of the following companies, or any of their
subsidiaries or affiliates, shall be Competing Organizations: 
  

	1.	Aetna* 

	2.	Amazing Charts 

	3.	athenahealth Inc. 

	4.	Cerner Corporation 

	5.	CPSI 

	6.	CSC* 

	7.	Danaher Corporation 

	8.	Dell* 

	9.	eClinicalWorks Inc. 

	10.	e-MDs 

	11.	Emdeon Business Services LLC 

	12.	Epic Systems Corporation 

	13.	Fujitsu* 

	14.	General Electric Company* 

	15.	Greenway Medical 

	16.	Humedica, Inc. 

	17.	IBM* 

	18.	McKesson Corporation 

	19.	Meditech 

	20.	Microsoft* 

	21.	NextGen 

	22.	OPTUMinsight 

	23.	Oracle* 

	24.	Philips* 

	25.	Practice Fusion 

	26.	Quality Systems, Inc. 

	27.	SAP* 

	28.	Siemens* 

	29.	The Trizetto Group. Inc.* 

	30.	UnitedHealth 

	31.	Vitera Healthcare Solutions 

	32.	Wellsoft Corporation 

	33.	Xerox* 

  

	*	The restriction only applies to the extent that Executive’s employment or services relate to electronic health records, practice management systems or revenue cycle management software for physician offices or
hospitals. 

  
 B-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00230-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00230-of-00352.parquet"}]]